Psychedelic medicines: are they gaining traction in Europe?
European Pharmaceutical Review
APRIL 13, 2023
6 Therefore, the quality of data provided to regulators will be key in obtaining MAs and subsequently marketing of psychedelic medicines. 6 Therefore, the quality of data provided to regulators will be key in obtaining MAs and subsequently marketing of psychedelic medicines.
Let's personalize your content